SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-237014
Filing Date
2023-09-18
Accepted
2023-09-18 17:26:00
Documents
12
Period of Report
2023-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d552436d8k.htm   iXBRL 8-K 22084
  Complete submission text file 0001193125-23-237014.txt   139366

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bntc-20230913.xsd EX-101.SCH 2886
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20230913_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20230913_pre.xml EX-101.PRE 10836
6 EXTRACTED XBRL INSTANCE DOCUMENT d552436d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 231261930
SIC: 2834 Pharmaceutical Preparations